泥沼
发表于 2025-3-28 15:26:54
http://reply.papertrans.cn/19/1812/181142/181142_41.png
有常识
发表于 2025-3-28 20:42:39
Image Processing and Analysis of PET and Hybrid PET Imagingentation/registration and more recent image-based outcome modeling in the radiomics field. We further extend the discussion into hybrid anatomical functional combinations of PET/CT and PET/MR multimodalities.
皱痕
发表于 2025-3-29 01:29:34
Basics and Advances of Quantitative PET Imagingimple to calculate showing effectiveness in a number of malignancies, is prone to many technical and biological errors if not properly adjusted. All of the above have been reviewed in this chapter along with other new emerging volumetric and disease burden quantitative metrics.
grudging
发表于 2025-3-29 05:10:37
http://reply.papertrans.cn/19/1812/181142/181142_44.png
PALL
发表于 2025-3-29 09:41:48
http://reply.papertrans.cn/19/1812/181142/181142_45.png
ORE
发表于 2025-3-29 11:44:20
Magnetic Heads For High Density Recording,edicine departments. Facility design and shielding calculations are described and examples given. Challenges in keeping doses to the staff and public down are described with some of the approaches to keeping doses as low as reasonably achievable. Computed tomography (CT) technology and dose metrics
旧病复发
发表于 2025-3-29 16:07:11
http://reply.papertrans.cn/19/1812/181142/181142_47.png
cipher
发表于 2025-3-29 23:42:43
http://reply.papertrans.cn/19/1812/181142/181142_48.png
effrontery
发表于 2025-3-29 23:55:09
HDL in Infectious Diseases and Sepsisese radiopharmaceuticals is important to assure the safety of the product before the release for clinical use. For this reason, efficient and quick tests have been adopted to check the quality of radiopharmaceutical preparations and specific procedures have been published in each country or regions
Arroyo
发表于 2025-3-30 08:00:50
HDL in Infectious Diseases and Sepsis from a regulatory point of view as both pharmaceutical good manufacturing practice (GMP) and radiation safety aspects have to be balanced against each other. As a consequence of this, the production of PET radiopharmaceuticals must comply with both GMP and local radiation safety rules. This chapter